Abstract
Dendritic cells (DCs) are the most potent antigen-presenting cells and acquire cellular antigens and danger signals from dying cells to initiate antitumor immune responses via direct cell-to-cell interaction and cytokine production. The optimal forms of tumor cell death for priming DCs for the release of danger signals are not fully understood. OBP-301 (Telomelysin) is a telomerase-specific replication-competent adenovirus that induces selective E1 expression and exclusively kills human cancer cells. Here, we show that OBP-301 replication produced the endogenous danger signaling molecule, uric acid, in infected human tumor cells, which in turn stimulated DCs to produce interferon-γ (IFN-γ) and interleukin 12 (IL-12). Subsequently, IFN-γ release upregulated the endogenous expression of the proteasome activator PA28 in tumor cells and resulted in the induction of cytotoxic T-lymphocytes. Our data suggest that virus-mediated oncolysis might be the effective stimulus for immature DCs to induce specific activity against human cancer cells.
Original language | English |
---|---|
Pages (from-to) | 2375-2381 |
Number of pages | 7 |
Journal | Oncogene |
Volume | 27 |
Issue number | 17 |
DOIs | |
Publication status | Published - Apr 10 2008 |
Keywords
- Adenovirus
- Danger signal
- Dendritic cell
- Telomerase
- Uric acid
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Cancer Research